Partin et al developed a score for predicting the risk of disease recurrence following radical prostatectomy for prostate cancer. This can help identify high risk patients who may benefit from more aggressive management. The authors are from the Johns Hopkins University and the University of North Carolina.
Patient: clinical (not pathologic) stage T2b or T2c
Parameters for proportional hazard multiple regression model:
(1) sigmoid transformation of the preoperative PSA (see chapter 16)
(2) Gleason score on the prostatectomy specimen
(3) tumor confinement in the radical prostatectomy specimen
Parameter |
Finding |
Points |
specimen confinement |
specimen confined |
0 |
|
not specimen confined |
1 |
where:
• The tumor was termed "not specimen confined" as (a) capsular penetration AND (b) one or more of the following: positive surgical margin, positive lymph node, and/or positive seminal vesicle.
relative risk of recurrence =
= (0.061 * (transformed PSA)) + (0.54 * (Gleason score)) + (1.87 * (points for specimen confinement))
Interpretation:
• The higher the score the greater the risk of PSA recurrence.
Relative Risk |
Risk Group |
< 4.0 |
low |
4.0 to 5.74 |
intermediate |
>= 5.75 |
high |
where:
• The paper uses 5.75 in the tables and text, but 5.57 in the figures.
• A value of 5.75 is unspecified in the paper (intermediate group is < 5.75 and high risk is > 5.75).
Specialty: Hematology Oncology, Surgery, general, Urology
ICD-10: ,